Akari Therapeutics (AKTX) Shareholder's Equity Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.87% |
| Dec 31, 2025 | 27.44% |
| Sep 30, 2025 | 438.92% |
| Jun 30, 2025 | 791.47% |
| Mar 31, 2025 | 712.05% |
| Dec 31, 2024 | 9,806.99% |
| Sep 30, 2024 | -3,242.72% |
| Jun 30, 2024 | -233.15% |
| Mar 31, 2024 | -154.15% |
| Dec 31, 2023 | -112.79% |
| Jun 30, 2023 | -66.60% |
| Mar 31, 2023 | -52.90% |
| Dec 31, 2022 | -67.76% |
| Jun 30, 2022 | 424.30% |
| Mar 31, 2022 | 253.87% |
| Sep 30, 2021 | 63.53% |
| Jun 30, 2021 | -73.34% |
| Mar 31, 2021 | 20.44% |
| Sep 30, 2020 | 41.73% |
| Jun 30, 2020 | 1,196.87% |
| Mar 31, 2020 | -32.49% |
| Dec 31, 2019 | -99.83% |
| Sep 30, 2019 | -96.20% |
| Jun 30, 2019 | -98.00% |
| Mar 31, 2019 | 2,479.76% |
| Dec 31, 2018 | -80.35% |
| Sep 30, 2018 | 888.35% |
| Jun 30, 2018 | 0.33% |
| Mar 31, 2018 | -100.91% |
| Dec 31, 2017 | -34.80% |
| Sep 30, 2017 | -68.22% |
| Jun 30, 2017 | -43.69% |
| Mar 31, 2017 | -51.69% |
| Dec 31, 2016 | -30.00% |
| Sep 30, 2016 | -0.71% |
| Jun 30, 2016 | 4,071.02% |
| Mar 31, 2016 | 1,686.44% |
| Dec 31, 2015 | 2,091.32% |
| Jun 30, 2015 | -90.66% |
| Dec 31, 2014 | 454.87% |
| Dec 31, 2013 | 111.93% |
| Dec 31, 2012 | -35.21% |